Sanford's Oxgaard: Not Optimistic on Bayer-Monsanto Deal(Audio)
(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.
GUEST:
Jonas Oxgaard, Chemicals Equity Analyst at Sanford Bernstein, weighs in on Bayer AG's bid for Monsanto: he's not optimistic the deal will go through.
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"The Tape","authorlink":""},"src":"https:\/\/www.podtrac.com\/pts\/redirect.mp3\/traffic.megaphone.fm\/BLM2691844481.mp3","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202109\/0a8c0a-0f42-1b1e-e7a77e_800.jpg"},"title":"Sanford's Oxgaard: Not Optimistic on Bayer-Monsanto Deal(Audio)","link":"javascript:;","id":"item-78203"}]
